Cargando…

Common UGT1A6 Variant Alleles Determine Acetaminophen Pharmacokinetics in Man

Acetaminophen (paracetamol) is a widely used drug that causes adverse drug events that are often dose-dependent and related to plasma drug concentrations. Acetaminophen metabolism strongly depends on UGT1A enzymes. We aimed to investigate putative factors influencing acetaminophen pharmacokinetics....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerezo-Arias, María de las Olas, Gómez-Tabales, Javier, Martí, Manuel, García-Martín, Elena, Agúndez, José A. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143054/ https://www.ncbi.nlm.nih.gov/pubmed/35629143 http://dx.doi.org/10.3390/jpm12050720

Ejemplares similares

Association between LAG3/CD4 gene variants and risk of Parkinson's disease
por: García‐Martín, Elena, et al.
Publicado: (2022)

Modulation of CYP2C9 activity and hydrogen peroxide production by cytochrome b(5)
por: Gómez-Tabales, Javier, et al.
Publicado: (2020)

Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity
por: Zillen, Daan, et al.
Publicado: (2021)

Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen
por: Zhao, Yanli, et al.
Publicado: (2015)

Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen
por: Mehboob, Huma, et al.
Publicado: (2017)

Comprehensive Variant Screening of the UGT Gene Family
por: Kim, Jason Yongha, et al.
Publicado: (2014)

Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients
por: So, W. Venus, et al.
Publicado: (2018)

Physiologically‐Based Pharmacokinetic Modeling of the Drug–Drug Interaction of the UGT Substrate Ertugliflozin Following Co‐Administration with the UGT Inhibitor Mefenamic Acid
por: Callegari, Ernesto, et al.
Publicado: (2020)

Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects
por: Sun, Lu‐Ning, et al.
Publicado: (2020)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
por: Calleja, Sofía, et al.
Publicado: (2023)

Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in Children
por: Jiang, X-L, et al.
Publicado: (2013)

Common Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphisms are not Related With the Risk for Restless Legs Syndrome
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Modelling Tools to Characterize Acetaminophen Pharmacokinetics in the Pregnant Population
por: Brookhuis, Sofie A. M., et al.
Publicado: (2021)

Acetaminophen pharmacokinetics in infants and children with congenital heart disease
por: Holladay, Jay, et al.
Publicado: (2022)

Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers
por: Guzmán, Nora Angélica Núñez, et al.
Publicado: (2016)

Clinical significance of the UGT1A1*28 allele detection in HIV-infected patients
por: Kanestri, Veronika, et al.
Publicado: (2014)

Analysis of the UGT1A1 Genotype in Hyperbilirubinemia Patients: Differences in Allele Frequency and Distribution
por: Mi, Xiao-xiao, et al.
Publicado: (2019)

Association between LAG3/CD4 Genes Variants and Risk for Multiple Sclerosis
por: García-Martín, Elena, et al.
Publicado: (2022)

Pharmacokinetics of mitragynine in man
por: Trakulsrichai, Satariya, et al.
Publicado: (2015)

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
por: Panagopoulos, Periklis, et al.
Publicado: (2017)

Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics
por: Hirvensalo, Päivi, et al.
Publicado: (2017)

Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell lines
por: Maszczak-Seneczko, Dorota, et al.
Publicado: (2011)

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain
por: Bravo-Gómez, Adrián, et al.
Publicado: (2022)

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015)

Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goats
por: ELBADAWY, Mohamed, et al.
Publicado: (2015)

Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
Publicado: (2015)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
por: Maeda, Hiromichi, et al.
Publicado: (2014)

Impact of UGT2B17 gene deletion on the steroid profile of an athlete
por: Martín‐Escudero, Pilar, et al.
Publicado: (2015)

Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI
por: Lee, Lawrence Soon-U, et al.
Publicado: (2016)

Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir
por: Patel, Parul, et al.
Publicado: (2020)

LAG3/CD4 Genes Variants and the Risk for Restless Legs Syndrome
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Systematic investigation of allelic regulatory activity of schizophrenia-associated common variants
por: McAfee, Jessica C., et al.
Publicado: (2023)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
por: Naidoo, Anushka, et al.
Publicado: (2017)

The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)‐Warfarin
por: Wanounou, Maor, et al.
Publicado: (2022)

Historia de la UGT.
Publicado: (2008)

Predicting Flavonoid UGT Regioselectivity
por: Jackson, Rhydon, et al.
Publicado: (2011)

Bee Products as Interesting Natural Agents for the Prevention and Treatment of Common Cardiovascular Diseases
por: Olas, Beata
Publicado: (2022)

The century of the common man
por: Wallace, Henry Agard, 1888-1965
Publicado: (1943)

Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients
por: Mazidi, Talia, et al.
Publicado: (2013)

Pharmacogenetics of uridine diphosphate glucuronosyltransferase (UGT2B7) genetic polymorphism on valproic acid pharmacokinetics in epilepsy
por: Munisamy, Murali, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_abg96mcbd6h41ig1450i29i67d